A new predictive tool has been developed to assess the risk of 18 obesity-related complications by integrating BMI with family history, diet, current illnesses, and socioeconomic factors. This advancement offers developers and tech professionals a more nuanced approach to identifying candidates for obesity medications like GLP-1 drugs. The model could streamline personalized treatment plans, improving patient outcomes and resource allocation in healthcare settings.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



